“…The most immediate application is in the investigation of patients who meet clinical and immunological criteria for developing periodontitis by using high‐throughput salivary biomarker validation tools for rapid chair‐side testing (Brinkmann et al, ; Korte & Kinney, ; Van Dyke, ). In addition, the authors expect that the confirmation of involvement of this pathway in periodontal diseases will be of importance for the management of periodontitis by inducing SPMs as novel drug targets to extend the pharmaceutical armamentarium to combat chronic inflammation, thus controlling periodontal inflammation, reversing pathologic changes related to the human microbiome, therefore promoting tissue regeneration and return to homeostasis (Grover et al, ; Hasturk & Kantarci, ; Tarannum & Faizuddin, ; Van Dyke, , ).…”